Myastig 0.5mg 1ml Injection

Myastig 0.5mg 1ml Injection contains Neostigmine Methylsulphate, a cholinesterase inhibitor used to reverse the effects of muscle relaxants after surgery and manage conditions like myasthenia gravis.

Benefits

Myastig 0.5mg 1ml Injection works by increasing acetylcholine levels at neuromuscular junctions, which helps improve muscle contraction and strength. It is crucial for restoring muscle function post-surgery and in conditions causing muscle weakness.

Uses and Indications

• Reversal of non-depolarizing neuromuscular blocking agents after surgery.
• Treatment of myasthenia gravis.
• Prevention and treatment of post-operative intestinal atony and urinary retention.

The Myastig 0.5mg 1ml Injection contains:

• Neostigmine Methylsulphate IP 0.5mg/ML (active ingredient).
• Excipients: phenol (as preservative), sodium acetate trihydrate, water for injection, with pH adjusted by acetic acid/sodium hydroxide.

Dosage and Administration

Myastig 0.5mg 1ml Injection should be administered by trained healthcare providers. The dosage is individualized and depends on the specific condition being treated and the patient's response. For reversal of neuromuscular blockade, doses typically range from 0.03 mg/kg to 0.07 mg/kg, given by slow intravenous injection, often concomitantly with an anticholinergic agent like atropine or glycopyrrolate. For myasthenia gravis or post-operative conditions, doses may be given intramuscularly or subcutaneously as directed by a doctor.

Storage and Disposal

• Store below 25°C, protected from light.
• Keep out of reach of children.

Precautions and Safety

• Administer with caution in patients with coronary artery disease, cardiac arrhythmias, recent acute coronary syndrome, epilepsy, vagotonia, hyperthyroidism, peptic ulceration, or Parkinson's disease.
• Contraindicated in patients with known hypersensitivity to neostigmine methylsulphate, peritonitis, or mechanical obstruction of the intestinal or urinary tract.
• An anticholinergic agent (e.g., atropine or glycopyrrolate) should be administered prior to or concomitantly with Myastig 0.5mg 1ml Injection to lessen the risk of bradycardia.

Side Effects and Risks

• Common side effects include nausea, vomiting, diarrhea, abdominal cramps, excessive salivation, increased sweating, and slow heart rate (bradycardia).
• Serious side effects can include severe cholinergic reactions, increased muscle weakness, and difficulty breathing. Consult a doctor if these or other severe symptoms occur.

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.